APO Research
Talk to an analyst

APO RESEARCH · REPORT

Computer-assisted Drug Design Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Computer-assisted Drug Design Platform Market Analysis and Forecast 2026-2032

2 May 2026206 pages

Choose your research edition.

Industry ResearchComputer-assisted Drug Design Platform Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Computer-assisted Drug Design Platform Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Computer-assisted Drug Design Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computer-assisted Drug Design Platform Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Computer-assisted Drug Design Platform Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Computer-assisted Drug Design Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Computer-assisted Drug Design Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Computer-assisted Drug Design Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Computer-assisted Drug Design Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Computer-assisted Drug Design Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Computer-assisted Drug Design Platform include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Computer-assisted Drug Design Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Computer-assisted Drug Design Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Computer-assisted Drug Design Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Computer-assisted Drug Design Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Computer-assisted Drug Design Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Computer-assisted Drug Design Platform revenue, projected growth trends, production technology, application and end-user industry.

Computer-assisted Drug Design Platform Segment by Company

Entelos

Crown Bioscience

Chemical Computing Group

Nimbus Therapeutics

Schrodinger

Dassault Systemes

Genedata

Biognos

Leadscope

Rhenovia Pharma Limited

Compugen

Certara LP

Prosarix

Simulations Plus

Strand Life Sciences

Computer-assisted Drug Design Platform Segment by Type

Cloud-based

On-premise

Computer-assisted Drug Design Platform Segment by Application

Drug Discovery and Development

Computational Physiological Medicine

Disease Modeling

Medical Imaging

Predictive Analysis of Drug Targets

Computer-assisted Drug Design Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computer-assisted Drug Design Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computer-assisted Drug Design Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computer-assisted Drug Design Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Computer-assisted Drug Design Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Computer-assisted Drug Design Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Computer-assisted Drug Design Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Computer-assisted Drug Design Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-premise Major Player Table 4. Global Computer-assisted Drug Design Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Drug Discovery and Development Major Player Table 6. Computational Physiological Medicine Major Player Table 7. Disease Modeling Major Player Table 8. Medical Imaging Major Player Table 9. Predictive Analysis of Drug Targets Major Player Table 10. Computer-assisted Drug Design Platform Industry Trends Table 11. Computer-assisted Drug Design Platform Industry Drivers Table 12. Computer-assisted Drug Design Platform Industry Opportunities and Challenges Table 13. Computer-assisted Drug Design Platform Industry Restraints Table 14. Global Computer-assisted Drug Design Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Computer-assisted Drug Design Platform Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Computer-assisted Drug Design Platform Market Share by Region (2021-2026) Table 17. Global Computer-assisted Drug Design Platform Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Computer-assisted Drug Design Platform Market Share by Region (2027-2032) Table 19. Global Computer-assisted Drug Design Platform Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Computer-assisted Drug Design Platform Revenue Market Share by Players (2021-2026) Table 21. Global Computer-assisted Drug Design Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Computer-assisted Drug Design Platform Key Players Headquarters & Area Served Table 23. Global Computer-assisted Drug Design Platform Players, Product Type & Application Table 24. Global Computer-assisted Drug Design Platform Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Computer-assisted Drug Design Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Computer-assisted Drug Design Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Computer-assisted Drug Design Platform Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Computer-assisted Drug Design Platform Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Computer-assisted Drug Design Platform Revenue Market Share by Type (2021-2026) Table 31. Global Computer-assisted Drug Design Platform Revenue Market Share by Type (2027-2032) Table 32. Global Computer-assisted Drug Design Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Computer-assisted Drug Design Platform Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Computer-assisted Drug Design Platform Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Computer-assisted Drug Design Platform Revenue Market Share by Application (2021-2026) Table 36. Global Computer-assisted Drug Design Platform Revenue Market Share by Application (2027-2032) Table 37. Entelos Company Information Table 38. Entelos Business Overview Table 39. Entelos Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Entelos Computer-assisted Drug Design Platform Product Portfolio Table 41. Entelos Recent Development Table 42. Crown Bioscience Company Information Table 43. Crown Bioscience Business Overview Table 44. Crown Bioscience Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Crown Bioscience Computer-assisted Drug Design Platform Product Portfolio Table 46. Crown Bioscience Recent Development Table 47. Chemical Computing Group Company Information Table 48. Chemical Computing Group Business Overview Table 49. Chemical Computing Group Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Chemical Computing Group Computer-assisted Drug Design Platform Product Portfolio Table 51. Chemical Computing Group Recent Development Table 52. Nimbus Therapeutics Company Information Table 53. Nimbus Therapeutics Business Overview Table 54. Nimbus Therapeutics Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Nimbus Therapeutics Computer-assisted Drug Design Platform Product Portfolio Table 56. Nimbus Therapeutics Recent Development Table 57. Schrodinger Company Information Table 58. Schrodinger Business Overview Table 59. Schrodinger Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Schrodinger Computer-assisted Drug Design Platform Product Portfolio Table 61. Schrodinger Recent Development Table 62. Dassault Systemes Company Information Table 63. Dassault Systemes Business Overview Table 64. Dassault Systemes Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Dassault Systemes Computer-assisted Drug Design Platform Product Portfolio Table 66. Dassault Systemes Recent Development Table 67. Genedata Company Information Table 68. Genedata Business Overview Table 69. Genedata Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Genedata Computer-assisted Drug Design Platform Product Portfolio Table 71. Genedata Recent Development Table 72. Biognos Company Information Table 73. Biognos Business Overview Table 74. Biognos Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Biognos Computer-assisted Drug Design Platform Product Portfolio Table 76. Biognos Recent Development Table 77. Leadscope Company Information Table 78. Leadscope Business Overview Table 79. Leadscope Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Leadscope Computer-assisted Drug Design Platform Product Portfolio Table 81. Leadscope Recent Development Table 82. Rhenovia Pharma Limited Company Information Table 83. Rhenovia Pharma Limited Business Overview Table 84. Rhenovia Pharma Limited Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product Portfolio Table 86. Rhenovia Pharma Limited Recent Development Table 87. Compugen Company Information Table 88. Compugen Business Overview Table 89. Compugen Computer-assisted Drug Design Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Compugen Computer-assisted Drug Design Platform Product Portfolio Table 91. Compugen Recent Development Table 92. Certara LP Company Information Table 93. Certara LP Business Overview Table 94. Certara LP Computer-assisted Drug Design Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Certara LP Computer-assisted Drug Design Platform Product Portfolio Table 96. Certara LP Recent Development Table 97. Prosarix Company Information Table 98. Prosarix Business Overview Table 99. Prosarix Computer-assisted Drug Design Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Prosarix Computer-assisted Drug Design Platform Product Portfolio Table 101. Prosarix Recent Development Table 102. Simulations Plus Company Information Table 103. Simulations Plus Business Overview Table 104. Simulations Plus Computer-assisted Drug Design Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Simulations Plus Computer-assisted Drug Design Platform Product Portfolio Table 106. Simulations Plus Recent Development Table 107. Strand Life Sciences Company Information Table 108. Strand Life Sciences Business Overview Table 109. Strand Life Sciences Computer-assisted Drug Design Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Strand Life Sciences Computer-assisted Drug Design Platform Product Portfolio Table 111. Strand Life Sciences Recent Development Table 112. North America Computer-assisted Drug Design Platform Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Computer-assisted Drug Design Platform Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Computer-assisted Drug Design Platform Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Computer-assisted Drug Design Platform Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Computer-assisted Drug Design Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Computer-assisted Drug Design Platform Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Computer-assisted Drug Design Platform Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Computer-assisted Drug Design Platform Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Computer-assisted Drug Design Platform Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Computer-assisted Drug Design Platform Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Computer-assisted Drug Design Platform Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Computer-assisted Drug Design Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Computer-assisted Drug Design Platform Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Computer-assisted Drug Design Platform Revenue by Country (US$ Million) & (2027-2032) Table 126. China Computer-assisted Drug Design Platform Revenue by Type (2021-2026) & (US$ Million) Table 127. China Computer-assisted Drug Design Platform Revenue by Type (2027-2032) & (US$ Million) Table 128. China Computer-assisted Drug Design Platform Revenue by Application (2021-2026) & (US$ Million) Table 129. China Computer-assisted Drug Design Platform Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Computer-assisted Drug Design Platform Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Computer-assisted Drug Design Platform Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Computer-assisted Drug Design Platform Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Computer-assisted Drug Design Platform Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Computer-assisted Drug Design Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Computer-assisted Drug Design Platform Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Computer-assisted Drug Design Platform Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Computer-assisted Drug Design Platform Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA Computer-assisted Drug Design Platform Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA Computer-assisted Drug Design Platform Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA Computer-assisted Drug Design Platform Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA Computer-assisted Drug Design Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Computer-assisted Drug Design Platform Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Computer-assisted Drug Design Platform Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Computer-assisted Drug Design Platform Image Figure 2. Global Computer-assisted Drug Design Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Computer-assisted Drug Design Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premise Image Figure 6. Global Computer-assisted Drug Design Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Computer-assisted Drug Design Platform Market Size Share 2021 VS 2025 VS 2032 Figure 8. Drug Discovery and Development Image Figure 9. Computational Physiological Medicine Image Figure 10. Disease Modeling Image Figure 11. Medical Imaging Image Figure 12. Predictive Analysis of Drug Targets Image Figure 13. Global Computer-assisted Drug Design Platform Market Size (US$ Million) & (2021-2032) Figure 14. Global Computer-assisted Drug Design Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Computer-assisted Drug Design Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Computer-assisted Drug Design Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Computer-assisted Drug Design Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Computer-assisted Drug Design Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Computer-assisted Drug Design Platform Revenue Market Share by Type (2021-2032) Figure 21. Global Computer-assisted Drug Design Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Computer-assisted Drug Design Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Computer-assisted Drug Design Platform Revenue Market Share by Application (2021-2032) Figure 24. North America Computer-assisted Drug Design Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032) Figure 26. North America Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032) Figure 27. North America Computer-assisted Drug Design Platform Revenue Share by Country (2021-2032) Figure 28. United States Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Computer-assisted Drug Design Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032) Figure 33. Europe Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032) Figure 34. Europe Computer-assisted Drug Design Platform Revenue Share by Country (2021-2032) Figure 35. Germany Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Computer-assisted Drug Design Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032) Figure 45. China Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032) Figure 46. Asia Computer-assisted Drug Design Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032) Figure 48. Asia Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032) Figure 49. Asia Computer-assisted Drug Design Platform Revenue Share by Region (2021-2032) Figure 50. Japan Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Computer-assisted Drug Design Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032) Figure 58. SAMEA Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032) Figure 59. SAMEA Computer-assisted Drug Design Platform Revenue Share by Country (2021-2032) Figure 60. Brazil Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Computer-assisted Drug Design Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Drug Discovery and Development
  • Computational Physiological Medicine
  • Disease Modeling
  • Medical Imaging
  • Predictive Analysis of Drug Targets
Companies covered
  • Entelos
  • Crown Bioscience
  • Chemical Computing Group
  • Nimbus Therapeutics
  • Schrodinger
  • Dassault Systemes
  • Genedata
  • Biognos
  • Leadscope
  • Rhenovia Pharma Limited
  • Compugen
  • Certara LP
  • Prosarix
  • Simulations Plus
  • Strand Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Computer-assisted Drug Design Platform Market by Type
  3. 1.2.1 Global Computer-assisted Drug Design Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premise
  6. 1.3 Computer-assisted Drug Design Platform Market by Application
  7. 1.3.1 Global Computer-assisted Drug Design Platform Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Drug Discovery and Development
  9. 1.3.3 Computational Physiological Medicine
  10. 1.3.4 Disease Modeling
  11. 1.3.5 Medical Imaging
  12. 1.3.6 Predictive Analysis of Drug Targets
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Computer-assisted Drug Design Platform Market Dynamics
  1. 2.1 Computer-assisted Drug Design Platform Industry Trends
  2. 2.2 Computer-assisted Drug Design Platform Industry Drivers
  3. 2.3 Computer-assisted Drug Design Platform Industry Opportunities and Challenges
  4. 2.4 Computer-assisted Drug Design Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Computer-assisted Drug Design Platform Market Perspective (2021-2032)
  2. 3.2 Global Computer-assisted Drug Design Platform Growth Trends by Region
  3. 3.2.1 Global Computer-assisted Drug Design Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Computer-assisted Drug Design Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Computer-assisted Drug Design Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Computer-assisted Drug Design Platform Revenue by Players
  2. 4.1.1 Global Computer-assisted Drug Design Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Computer-assisted Drug Design Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Computer-assisted Drug Design Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Computer-assisted Drug Design Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Computer-assisted Drug Design Platform Key Players Headquarters & Area Served
  7. 4.4 Global Computer-assisted Drug Design Platform Players, Product Type & Application
  8. 4.5 Global Computer-assisted Drug Design Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Computer-assisted Drug Design Platform Market CR5 and HHI
  11. 4.6.3 2025 Computer-assisted Drug Design Platform Tier 1, Tier 2, and Tier 3
5 Computer-assisted Drug Design Platform Market Size by Type
  1. 5.1 Global Computer-assisted Drug Design Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Computer-assisted Drug Design Platform Revenue by Type (2021-2032)
  3. 5.3 Global Computer-assisted Drug Design Platform Revenue Market Share by Type (2021-2032)
6 Computer-assisted Drug Design Platform Market Size by Application
  1. 6.1 Global Computer-assisted Drug Design Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Computer-assisted Drug Design Platform Revenue by Application (2021-2032)
  3. 6.3 Global Computer-assisted Drug Design Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Entelos
  2. 7.1.1 Entelos Company Information
  3. 7.1.2 Entelos Business Overview
  4. 7.1.3 Entelos Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Entelos Computer-assisted Drug Design Platform Product Portfolio
  6. 7.1.5 Entelos Recent Developments
  7. 7.2 Crown Bioscience
  8. 7.2.1 Crown Bioscience Company Information
  9. 7.2.2 Crown Bioscience Business Overview
  10. 7.2.3 Crown Bioscience Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Crown Bioscience Computer-assisted Drug Design Platform Product Portfolio
  12. 7.2.5 Crown Bioscience Recent Developments
  13. 7.3 Chemical Computing Group
  14. 7.3.1 Chemical Computing Group Company Information
  15. 7.3.2 Chemical Computing Group Business Overview
  16. 7.3.3 Chemical Computing Group Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Chemical Computing Group Computer-assisted Drug Design Platform Product Portfolio
  18. 7.3.5 Chemical Computing Group Recent Developments
  19. 7.4 Nimbus Therapeutics
  20. 7.4.1 Nimbus Therapeutics Company Information
  21. 7.4.2 Nimbus Therapeutics Business Overview
  22. 7.4.3 Nimbus Therapeutics Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Nimbus Therapeutics Computer-assisted Drug Design Platform Product Portfolio
  24. 7.4.5 Nimbus Therapeutics Recent Developments
  25. 7.5 Schrodinger
  26. 7.5.1 Schrodinger Company Information
  27. 7.5.2 Schrodinger Business Overview
  28. 7.5.3 Schrodinger Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Schrodinger Computer-assisted Drug Design Platform Product Portfolio
  30. 7.5.5 Schrodinger Recent Developments
  31. 7.6 Dassault Systemes
  32. 7.6.1 Dassault Systemes Company Information
  33. 7.6.2 Dassault Systemes Business Overview
  34. 7.6.3 Dassault Systemes Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Dassault Systemes Computer-assisted Drug Design Platform Product Portfolio
  36. 7.6.5 Dassault Systemes Recent Developments
  37. 7.7 Genedata
  38. 7.7.1 Genedata Company Information
  39. 7.7.2 Genedata Business Overview
  40. 7.7.3 Genedata Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Genedata Computer-assisted Drug Design Platform Product Portfolio
  42. 7.7.5 Genedata Recent Developments
  43. 7.8 Biognos
  44. 7.8.1 Biognos Company Information
  45. 7.8.2 Biognos Business Overview
  46. 7.8.3 Biognos Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Biognos Computer-assisted Drug Design Platform Product Portfolio
  48. 7.8.5 Biognos Recent Developments
  49. 7.9 Leadscope
  50. 7.9.1 Leadscope Company Information
  51. 7.9.2 Leadscope Business Overview
  52. 7.9.3 Leadscope Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Leadscope Computer-assisted Drug Design Platform Product Portfolio
  54. 7.9.5 Leadscope Recent Developments
  55. 7.10 Rhenovia Pharma Limited
  56. 7.10.1 Rhenovia Pharma Limited Company Information
  57. 7.10.2 Rhenovia Pharma Limited Business Overview
  58. 7.10.3 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product Portfolio
  60. 7.10.5 Rhenovia Pharma Limited Recent Developments
  61. 7.11 Compugen
  62. 7.11.1 Compugen Company Information
  63. 7.11.2 Compugen Business Overview
  64. 7.11.3 Compugen Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Compugen Computer-assisted Drug Design Platform Product Portfolio
  66. 7.11.5 Compugen Recent Developments
  67. 7.12 Certara LP
  68. 7.12.1 Certara LP Company Information
  69. 7.12.2 Certara LP Business Overview
  70. 7.12.3 Certara LP Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Certara LP Computer-assisted Drug Design Platform Product Portfolio
  72. 7.12.5 Certara LP Recent Developments
  73. 7.13 Prosarix
  74. 7.13.1 Prosarix Company Information
  75. 7.13.2 Prosarix Business Overview
  76. 7.13.3 Prosarix Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Prosarix Computer-assisted Drug Design Platform Product Portfolio
  78. 7.13.5 Prosarix Recent Developments
  79. 7.14 Simulations Plus
  80. 7.14.1 Simulations Plus Company Information
  81. 7.14.2 Simulations Plus Business Overview
  82. 7.14.3 Simulations Plus Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Simulations Plus Computer-assisted Drug Design Platform Product Portfolio
  84. 7.14.5 Simulations Plus Recent Developments
  85. 7.15 Strand Life Sciences
  86. 7.15.1 Strand Life Sciences Company Information
  87. 7.15.2 Strand Life Sciences Business Overview
  88. 7.15.3 Strand Life Sciences Computer-assisted Drug Design Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Strand Life Sciences Computer-assisted Drug Design Platform Product Portfolio
  90. 7.15.5 Strand Life Sciences Recent Developments
8 North America
  1. 8.1 North America Computer-assisted Drug Design Platform Revenue (2021-2032)
  2. 8.2 North America Computer-assisted Drug Design Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Computer-assisted Drug Design Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Computer-assisted Drug Design Platform Revenue by Type (2027-2032)
  5. 8.3 North America Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Computer-assisted Drug Design Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Computer-assisted Drug Design Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Computer-assisted Drug Design Platform Revenue by Application (2027-2032)
  9. 8.5 North America Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Computer-assisted Drug Design Platform Revenue by Country
  11. 8.6.1 North America Computer-assisted Drug Design Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Computer-assisted Drug Design Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Computer-assisted Drug Design Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Computer-assisted Drug Design Platform Revenue (2021-2032)
  2. 9.2 Europe Computer-assisted Drug Design Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Computer-assisted Drug Design Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Computer-assisted Drug Design Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Computer-assisted Drug Design Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Computer-assisted Drug Design Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Computer-assisted Drug Design Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Computer-assisted Drug Design Platform Revenue by Country
  11. 9.6.1 Europe Computer-assisted Drug Design Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Computer-assisted Drug Design Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Computer-assisted Drug Design Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Computer-assisted Drug Design Platform Revenue (2021-2032)
  2. 10.2 China Computer-assisted Drug Design Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Computer-assisted Drug Design Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Computer-assisted Drug Design Platform Revenue by Type (2027-2032)
  5. 10.3 China Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Computer-assisted Drug Design Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Computer-assisted Drug Design Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Computer-assisted Drug Design Platform Revenue by Application (2027-2032)
  9. 10.5 China Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Computer-assisted Drug Design Platform Revenue (2021-2032)
  2. 11.2 Asia Computer-assisted Drug Design Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Computer-assisted Drug Design Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Computer-assisted Drug Design Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Computer-assisted Drug Design Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Computer-assisted Drug Design Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Computer-assisted Drug Design Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Computer-assisted Drug Design Platform Revenue by Country
  11. 11.6.1 Asia Computer-assisted Drug Design Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Computer-assisted Drug Design Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Computer-assisted Drug Design Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Computer-assisted Drug Design Platform Revenue (2021-2032)
  2. 12.2 SAMEA Computer-assisted Drug Design Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Computer-assisted Drug Design Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Computer-assisted Drug Design Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Computer-assisted Drug Design Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Computer-assisted Drug Design Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Computer-assisted Drug Design Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Computer-assisted Drug Design Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Computer-assisted Drug Design Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Computer-assisted Drug Design Platform Revenue by Country
  11. 12.6.1 SAMEA Computer-assisted Drug Design Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Computer-assisted Drug Design Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Computer-assisted Drug Design Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst